Main complications of diabetic patients May-December 2020 IESS Guaranda hospital
Keywords:
Patent ductus arteriosus, patent canal arteriosus, congenital heart disease, neonates, pharmacological treatmentAbstract
The patent ductus arteriosus (DAP) is the congenital heart disease that occurs most frequently in newborns, generating a significant short circuit that generally needs its interruption by drug administration; in the country it is estimated that about 2,500 children are born each year with congenital heart defects.
General purpose: To determine the efficacy of pharmacological closure of persistent ductus arteriosus in neonates at the Francisco Icaza Bustamante Hospital between 2016-2019. Materials and methods: This are a descriptive, quantitative and descriptive investigation of retrospective analytical cross-section.
Results: Of 199 neonatal patients taken with a diagnosis of DAP, 82% (163 patients) were successful in closing the ductus with drugs vs. 18% (36 patients) without success in pharmacological closure; 169 neonates (84%) were treated with paracetamol versus 30 patients (15%) who were treated with ibuprofen; Drug-associated complications occurred in 18% (36 patients).
Conclusions: Having carried out and completed this investigation, it is shown that the pharmacological treatment for persistent ductus arteriosus is highly effective, with paracetamol being the most widely used drug at present and with a minimal rate of complications.
References
Pop-Busui R, Boulton AJM, Feldman EL, Bril V, Freeman R, Malik RA, Sosenko JM, Ziegler D. Diabetic Neuropathy: A Position Statement by the American Diabetes Association.
American Diabetes Association. Microvascular complications and foot care. Diabetes Care 2017.
Tesfaye S, Vileikyte L, Rayman G, Sindrup SH, Perkins BA, Baconja M, Vinik AI, Boulton AJM; on behalf of The Toronto Expert Panel on Diabetic Neuropathy. Painful diabetic peripheral neuropathy: consensus recommendations on diagnosis, assessment and management. Diabetes Metab Res Rev 2018.
Vinik AI, Maser RE, Mitchel BD, Freeman R. Diabetic autonomic neuropathy. Diabetes Care 2019.
Gæde P, Oellgaard J, Carstensen B, Rossing P, Lund-Andersen H, Parving H-H, Pedersen O. Years of life gained by multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: 21 years follow-up on the Steno-2 randomised trial. Diabetología (2016).
Jiménez CJ, Díaz CO, Barrabés JA, De la Villa BG, Peris VB, Palop RL, et al. Actualización en cardiopatía isquémica y cuidados críticos cardiológicos. Revista Española de Cardiología. 2016.
Ruiz JCR, Castillo MA, Castillo MIA. Study of Cardiovascular Risk in Immigrant and Spanish Diabetic Patients in the Province of Almeria. Procedia-Social and Behavioral Sciences.2016 Nov 27.
González MI. La enfermedad coronaria del diabético. Diagnóstico, pronóstico y tratamiento. Rev Esp Cardiol Supl. 2007:29H-41H. Consultado: 2016 Nov 20.
Standards of Medical Care in Diabetes-2017: Summary of Revisions. Diabetes Care [Internet]. 2017 Jan 15.
Rados D V, Pinto LC, Leitão CB, Gross JL. Screening for coronary artery disease in patients with type 2 diabetes: a meta-analysis and trial sequential analysis. BMJ Open [Internet]. 2017 May.
Pop-Busui R, Boulton AJM, Feldman EL, Bril V, Freeman R, Malik RA, Sosenko JM, Ziegler D. Diabetic Neuropathy: A Position Statement by the American Diabetes Association. Diabetes Care 2017.
American Diabetes Association. Microvascular complications and foot care. Diabetes Care 2017.
Lucato, P., Solmi, M., Maggi, S., Bertocco, A., Bano, G., Trevisan, C., Stubbs, B. (2019). Maturitas Low vitamin D levels increase the risk of type 2 diabetes in older adults.
Meijnikman, A. S., Block, C. E. M. De, Verrijken, A., Mertens, I., Corthouts, B., & Gaal, L. F. Van. (2019). Screening for type 2 diabetes mellitus in overweight and obese subjects made easy by the FINDRISC.
Pop-Busui R, Boulton AJM, Feldman EL, Bril V, Freeman R, Malik RA, Sosenko JM, Ziegler D. Diabetic Neuropathy: A Position Statement by the American Diabetes Association.
American Diabetes Association. Microvascular complications and foot care. Diabetes Care 2017.
Tesfaye S, Vileikyte L, Rayman G, Sindrup SH, Perkins BA, Baconja M, Vinik AI, Boulton AJM; on behalf of The Toronto Expert Panel on Diabetic Neuropathy. Painful diabetic peripheral neuropathy: consensus recommendations on diagnosis, assessment and management. Diabetes Metab Res Rev 2018.
Vinik AI, Maser RE, Mitchel BD, Freeman R. Diabetic autonomic neuropathy. Diabetes Care 2019.
